Prevail Therapeutics (PRVL) Provides Clinical Advancement Update on PR001 for Treatment of Parkinson’s Disease with GBA1 mutations Mar 3, 2020 07:07AM
Prevail Therapeutics Provides Clinical Advancement Update on PR001 for the Treatment of Parkinson’s Disease with GBA1 mutations Mar 3, 2020 07:00AM
Prevail Therapeutics Provides Clinical Advancement Update on PR001 for the Treatment of Parkinson’s Disease with GBA1 mutations Mar 3, 2020 07:00AM
Prevail Therapeutics to Present at Upcoming Conferences Feb 21, 2020 08:30AM
Prevail Therapeutics to Present at Upcoming Conferences Feb 21, 2020 08:30AM


Jul 15, 2019 05:35AM Cowen Starts Prevail Therapeutics (PRVL) at Outperform
Jun 20, 2019 12:45PM Prevail Therapeutics (PRVL) IPO Opens Lower
Jun 20, 2019 06:15AM Prevail Therapeutics Inc. (PRVL) Prices 7.35M Share IPO at $17/Sh
Jun 19, 2019 09:16PM Prevail Therapeutics Announces Pricing of Initial Public Offering